What is the CVR number of REPONEX PHARMACEUTICALS A/S?

REPONEX PHARMACEUTICALS A/S is registered with CVR / Virk under CVR 30082346.

How many employees does REPONEX PHARMACEUTICALS A/S have?

REPONEX PHARMACEUTICALS A/S employs 1 people as of the latest annual report.

Christian Henrik Tange is the CEO of REPONEX PHARMACEUTICALS A/S, in role since 2025.

Christian Vinding Thomsen chairs the board of REPONEX PHARMACEUTICALS A/S, in role since 2022.

REPONEX PHARMACEUTICALS A/S's registered address is Slotsmarken 12, 1. th.

A/SActiveAdvertising protection

CVR 30082346Slotsmarken 12, 2970 HørsholmManufacture of pharmaceutical preparations· NACE 2120Est. 2006 · 19 years old1 employeeswww.reponex.dk

Actively employed in the business

Name	Role	Member since
Current (1)
CH Christian Henrik Tange Chief Executive Officer	Chief Executive Officer	2025
Former (9)
MS Michael Secher Management	Management	2008 – 2010
TK Thomas Kaas Selsø Chief Executive Officer	Chief Executive Officer	2023 – 2025
TB Torsten Bjørn Management	Management	2016 – 2021
HL Henrik Lasse Lindblad Chief Executive Officer	Chief Executive Officer	2010 – 2016
MT Mikael Thiesen Management	Management	2006 – 2007
JS Jon Steffen Therkildsen Management	Management	2007 – 2008
SB Sebastian Bo Jakobsen Chief Executive Officer	Chief Executive Officer	2025 – 2025
KS Klaus Snej Jensen Chief Executive Officer	Chief Executive Officer	2021 – 2022
SG Sigbjørn Georg Nielsen Kjærgård Chief Executive Officer	Chief Executive Officer	2022 – 2023

Non-executive oversight

Name	Role	Member since
Current (3)
CV Christian Vinding Thomsen Chairman	Chairman	2022
CP Charlotte Pahl Board of Directors	Board of Directors	2018
TP Troels Peter Troelsen Deputy Chairman	Deputy Chairman	2021
Former (7)
PM Peter Mørch Eriksen Board of Directors	Board of Directors	2023 – 2023
MZ Mette Zacho Board of Directors	Board of Directors	2023 – 2023
HB Henrik Bulskov Board of Directors	Board of Directors	2015 – 2019
EL Erik Lennard Vitting Skovbjerg Board of Directors	Board of Directors	2016 – 2016
LT Lisbeth Thyregod Board of Directors	Board of Directors	2017 – 2023
JR Jacob Rosenberg Chairman	Chairman	2015 – 2015
KH Katrine Hoff Schlichtkrull Board of Directors	Board of Directors	2021 – 2021

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Pharma Equity Group A/S	Company	100%	100%	2023
DANISH MEDICAL CONSULTS ApS	Company	5–9.99%	5–9.99%	2018
Beier Holding ApS	Company	10–14.99%	10–14.99%	2019
NIELS ERIK JESPERSEN HOLDING ApS	Company	5–9.99%	5–9.99%	2019
CLINICURO ApS	Company	5–9.99%	5–9.99%	2014
VULKAN INVEST ApS	Company	5–9.99%	5–9.99%	2015
BIOPHARMA HOLDING ApS	Company	20–24.99%	20–24.99%	2017
BREGNERØDVEJ AUTO ApS	Company	5–9.99%	5–9.99%	2014
FINANSMANAGEMENT ApS	Company	5–9.99%	5–9.99%	2015

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.